|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 4/07/21 Huaizhong Health Group, Inc. 10-Q 1/31/21 25:813K Pubco Reporting … Inc/FA |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 173K
2: EX-31.1 Certification -- §302 - SOA'02 HTML 14K
3: EX-32.1 Certification -- §906 - SOA'02 HTML 10K
10: R1 Cover HTML 61K
11: R2 Balance Sheets HTML 44K
12: R3 Balance Sheets (Parenthetical) HTML 18K
13: R4 Statements of Operations (Unaudited) HTML 42K
14: R5 Statements of Changes in Stockholders Deficit HTML 20K
(Unaudited)
15: R6 Statements of Cash Flows (Unaudited) HTML 33K
16: R7 Summary of Significant Accounting Policies HTML 16K
17: R8 Going Concern HTML 14K
18: R9 Related Party Transactions HTML 13K
19: R10 Summary of Significant Accounting Policies HTML 20K
(Policies)
20: R11 Going Concern (Details Narrative) HTML 12K
21: R12 Related Party Transactions (Details Narrative) HTML 12K
23: XML IDEA XML File -- Filing Summary XML 34K
9: XML XBRL Instance -- huaizhong_10q_htm XML 113K
22: EXCEL IDEA Workbook of Financial Reports XLSX 18K
6: EX-101.CAL XBRL Calculations -- abcd-20210131_cal XML 45K
8: EX-101.DEF XBRL Definitions -- abcd-20210131_def XML 40K
5: EX-101.LAB XBRL Labels -- abcd-20210131_lab XML 188K
7: EX-101.PRE XBRL Presentations -- abcd-20210131_pre XML 132K
4: EX-101.SCH XBRL Schema -- abcd-20210131 XSD 36K
24: JSON XBRL Instance as JSON Data -- MetaLinks 63± 86K
25: ZIP XBRL Zipped Folder -- 0001640334-21-000798-xbrl Zip 38K
EXHIBIT 31.1
CERTIFICATION PURSUANT TO
EXCHANGE ACT RULES 13a-14(a) AND 15d-14(a),
AS ADOPTED PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Yuantong Wang, certify that:
| 1. | I have reviewed this quarterly report on Form 10-Q of Huaizhong Health Group, Inc.; |
|
|
|
| 2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
|
|
|
| 3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
|
|
|
| 4. | I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have; |
|
| a. | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to me by others within those entities, particularly during the period in which this report is being prepared; |
|
|
|
|
|
| b. | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
|
|
|
|
|
| c. | Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
|
|
|
|
|
| d. | Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
| 5. | I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions): |
|
| a. | All significant deficiencies and material weakness in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
|
|
|
|
|
| b. | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
| Date: April 7, 2021 | By: |
/s/ Yuantong Wang | |
|
|
|
| |
|
|
| Principal Executive Officer and Principal Financial Officer |
|
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 4/7/21 | |||
| For Period end: | 1/31/21 | NT 10-Q | ||
| List all Filings | ||||